204 related articles for article (PubMed ID: 24603967)
1. Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.
Banerjee T; Mukherjee S; Ghosh S; Biswas M; Dutta S; Pattari S; Chatterjee S; Bandyopadhyay A
PLoS One; 2014; 9(3):e90527. PubMed ID: 24603967
[TBL] [Abstract][Full Text] [Related]
2. Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.
Asrial AA; Reviono R; Soetrisno S; Setianto BY; Widyaningsih V; Nurwati I; Wasita B; Pudjiastuti A
Narra J; 2024 Apr; 4(1):e293. PubMed ID: 38798862
[TBL] [Abstract][Full Text] [Related]
3. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
[TBL] [Abstract][Full Text] [Related]
4. The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study.
Liu Q; Qiao WH; Li FF; Deng P; Hu ZW
J Heart Valve Dis; 2015 Jul; 24(4):496-501. PubMed ID: 26897823
[TBL] [Abstract][Full Text] [Related]
5. Is rheumatic mitral valve repair still a feasible alternative?: indications, technique, and results.
Bakir I; Onan B; Onan IS; Gul M; Uslu N
Tex Heart Inst J; 2013; 40(2):163-9. PubMed ID: 23678214
[TBL] [Abstract][Full Text] [Related]
6. Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification.
Aloui S; Zidi W; Ouali S; Guizani I; Hadj-Taieb S; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2018 Dec; 45(6):2135-2143. PubMed ID: 30302620
[TBL] [Abstract][Full Text] [Related]
7. [The characteristics of subvalvular lesions of excised rheumatic mitral valves].
Ishihara S; Hashimoto A; Koyanagi H
Kyobu Geka; 1985 Feb; 38(2):96-100. PubMed ID: 3990068
[No Abstract] [Full Text] [Related]
8. Aschoff bodies at necropsy in valvular heart disease. Evidence from an analysis of 543 patients over 14 years of age that rheumatic heart disease, at least anatomically, is a disease of the mitral valve.
Roberts WC; Virmani R
Circulation; 1978 Apr; 57(4):803-7. PubMed ID: 630691
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological analysis of rheumatic heart disease].
Okada R
J Cardiol; 1996; 27 Suppl 2():3-11; discussion 12-3. PubMed ID: 9067812
[TBL] [Abstract][Full Text] [Related]
10. Morphologic features of the rheumatic mitral regurgitant valve by three-dimensional echocardiography.
Wong S; French R; Bolson E; McDonald J; Legget M; Sheehan F
Am Heart J; 2001 Nov; 142(5):897-907. PubMed ID: 11685179
[TBL] [Abstract][Full Text] [Related]
11. Elevated fibrinogen and lowered homocysteine-vitamin determinants and their association with left atrial thrombus in patients with rheumatic mitral stenosis.
Murugesan V; Pulimamidi VK; Rajappa M; Satheesh S; Revathy G; Harichandrakumari KT
Br J Biomed Sci; 2015; 72(3):102-6. PubMed ID: 26510264
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
[TBL] [Abstract][Full Text] [Related]
13. Surgical pathology of the mitral valve: gross and histological study of 1288 surgically excised valves.
Agozzino L; Falco A; de Vivo F; de Vincentiis C; de Luca L; Esposito S; Cotrufo M
Int J Cardiol; 1992 Oct; 37(1):79-89. PubMed ID: 1428293
[TBL] [Abstract][Full Text] [Related]
14. Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
Martins CO; Demarchi L; Ferreira FM; Pomerantzeff PM; Brandao C; Sampaio RO; Spina GS; Kalil J; Cunha-Neto E; Guilherme L
PLoS One; 2017; 12(1):e0170191. PubMed ID: 28121998
[TBL] [Abstract][Full Text] [Related]
15. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
Cevik C; Otahbachi M; Nugent K; Ozkan M
J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
[TBL] [Abstract][Full Text] [Related]
16. Quantitative study of the mitral valve in chronic rheumatic heart disease.
Kinare SG; Kulkarni HL
Int J Cardiol; 1987 Sep; 16(3):271-84. PubMed ID: 3654026
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of individual normal, floppy and rheumatic human mitral valves.
Lis Y; Burleigh MC; Parker DJ; Child AH; Hogg J; Davies MJ
Biochem J; 1987 Jun; 244(3):597-603. PubMed ID: 3446179
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae.
Marcus RH; Sareli P; Pocock WA; Barlow JB
Ann Intern Med; 1994 Feb; 120(3):177-83. PubMed ID: 8043061
[TBL] [Abstract][Full Text] [Related]
19. Subvalvular apparatus and adverse outcome of balloon valvotomy in rheumatic mitral stenosis.
Bhalgat P; Karlekar S; Modani S; Agrawal A; Lanjewar C; Nabar A; Kerkar P; Agrawal N; Vaideeswar P
Indian Heart J; 2015; 67(5):428-33. PubMed ID: 26432729
[TBL] [Abstract][Full Text] [Related]
20. Fibrillin and other matrix proteins in mitral valve prolapse syndrome.
Nasuti JF; Zhang PJ; Feldman MD; Pasha T; Khurana JS; Gorman JH; Gorman RC; Narula J; Narula N
Ann Thorac Surg; 2004 Feb; 77(2):532-6. PubMed ID: 14759433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
